Logo


Trump win might mean opportunities for Indian pharma

Trump had proposed to lift entry barriers for drug makers that offer safe, reliable and cheaper products

Donald Trump
Donald Trump

Donald Trump's election as the US president will create opportunities for Indian generic drug makers, say pharmaceutical sector experts. While they and industry chief executives believe pricing pressure will continue in the US, the president-elect's proposal to lift entry barriers for safe, reliable and cheaper products bodes well for Indian companies, they said. As a part of his seven point health care agenda, Trump had said this would allow consumers access to better drugs made abroad. "I expect Donald Trump will remove restrictions on drug imports. This will ...